229 related articles for article (PubMed ID: 8553588)
1. Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107.
McIntyre MC; Ruesch MN; Laimins LA
Virology; 1996 Jan; 215(1):73-82. PubMed ID: 8553588
[TBL] [Abstract][Full Text] [Related]
2. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
[TBL] [Abstract][Full Text] [Related]
3. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
Kiess M; Gill RM; Hamel PA
Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
[TBL] [Abstract][Full Text] [Related]
4. E1A modulates phosphorylation of p130 and p107 by differentially regulating the activity of G1/S cyclin/CDK complexes.
Parreño M; Garriga J; Limón A; Albrecht JH; Graña X
Oncogene; 2001 Aug; 20(35):4793-806. PubMed ID: 11521191
[TBL] [Abstract][Full Text] [Related]
5. Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity.
Ruesch MN; Laimins LA
J Virol; 1997 Jul; 71(7):5570-8. PubMed ID: 9188631
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells.
Ehmann GL; McLean TI; Bachenheimer SL
Virology; 2000 Feb; 267(2):335-49. PubMed ID: 10662629
[TBL] [Abstract][Full Text] [Related]
7. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
Nahum A; Hirsch K; Danilenko M; Watts CK; Prall OW; Levy J; Sharoni Y
Oncogene; 2001 Jun; 20(26):3428-36. PubMed ID: 11423993
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus oncoproteins alter differentiation-dependent cell cycle exit on suspension in semisolid medium.
Ruesch MN; Laimins LA
Virology; 1998 Oct; 250(1):19-29. PubMed ID: 9770416
[TBL] [Abstract][Full Text] [Related]
9. Differential patterns of cell cycle regulatory proteins expression in transgenic models of thyroid tumours.
Coppée F; Depoortere F; Bartek J; Ledent C; Parmentier M; Dumont JE
Oncogene; 1998 Aug; 17(5):631-41. PubMed ID: 9704929
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein.
Jones DL; Münger K
J Virol; 1997 Apr; 71(4):2905-12. PubMed ID: 9060648
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I.
Iwanaga R; Ohtani K; Hayashi T; Nakamura M
Oncogene; 2001 Apr; 20(17):2055-67. PubMed ID: 11360190
[TBL] [Abstract][Full Text] [Related]
12. Deregulation of specific E2F complexes by the v-mos oncogene.
Afshari CA; Rhodes N; Paules RS; Mudryj M
Oncogene; 1997 Jun; 14(25):3029-38. PubMed ID: 9223666
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of pRb2/p130 interaction with cyclins.
Claudio PP; De Luca A; Howard CM; Baldi A; Firpo EJ; Koff A; Paggi MG; Giordano A
Cancer Res; 1996 May; 56(9):2003-8. PubMed ID: 8616840
[TBL] [Abstract][Full Text] [Related]
14. A model of the G1 phase of the cell cycle incorporating cyclin E/cdk2 complex and retinoblastoma protein.
Obeyesekere MN; Herbert JR; Zimmerman SO
Oncogene; 1995 Sep; 11(6):1199-205. PubMed ID: 7566981
[TBL] [Abstract][Full Text] [Related]
15. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
Morris L; Allen KE; La Thangue NB
Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
[TBL] [Abstract][Full Text] [Related]
16. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF.
Zhang HS; Gavin M; Dahiya A; Postigo AA; Ma D; Luo RX; Harbour JW; Dean DC
Cell; 2000 Mar; 101(1):79-89. PubMed ID: 10778858
[TBL] [Abstract][Full Text] [Related]
17. Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins.
Zariwala M; Liu J; Xiong Y
Oncogene; 1998 Nov; 17(21):2787-98. PubMed ID: 9840943
[TBL] [Abstract][Full Text] [Related]
18. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2.
Jones DL; Alani RM; Münger K
Genes Dev; 1997 Aug; 11(16):2101-11. PubMed ID: 9284049
[TBL] [Abstract][Full Text] [Related]
19. Identification of a p130 domain mediating interactions with cyclin A/cdk 2 and cyclin E/cdk 2 complexes.
Lacy S; Whyte P
Oncogene; 1997 May; 14(20):2395-406. PubMed ID: 9188854
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
